Follow
Feilim Mac Gabhann
Feilim Mac Gabhann
Associate Professor of Biomedical Engineering, Johns Hopkins University
Verified email at jhu.edu
Title
Cited by
Cited by
Year
Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning
P Vempati, AS Popel, F Mac Gabhann
Cytokine & growth factor reviews 25 (1), 1-19, 2014
3662014
Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
C Kut, F Mac Gabhann, AS Popel
British journal of cancer 97 (7), 978-985, 2007
3452007
A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use
FTH Wu, MO Stefanini, FM Gabhann, CD Kontos, BH Annex, AS Popel
Journal of cellular and molecular medicine 14 (3), 528-552, 2010
2702010
Systems biology of vascular endothelial growth factors
FM Gabhann, AS Popel
Microcirculation 15 (8), 715-738, 2008
2602008
A systems biology view of blood vessel growth and remodelling
EA Logsdon, SD Finley, AS Popel, FM Gabhann
Journal of cellular and molecular medicine 18 (8), 1491-1508, 2014
2362014
Multiscale models of angiogenesis
AA Qutub, F Mac Gabhann, ED Karagiannis, P Vempati, AS Popel
IEEE engineering in medicine and biology magazine 28 (2), 14-31, 2009
1952009
A compartment model of VEGF distribution in blood, healthy and diseased tissues
MO Stefanini, FTH Wu, F Mac Gabhann, AS Popel
BMC systems biology 2, 1-25, 2008
1832008
Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells
F Mac Gabhann, AS Popel
American Journal of Physiology-Heart and Circulatory Physiology 286 (1 …, 2004
1742004
Design principles for therapeutic angiogenic materials
PS Briquez, LE Clegg, MM Martino, FM Gabhann, JA Hubbell
Nature Reviews Materials 1 (1), 1-15, 2016
1682016
Dimerization of VEGF receptors and implications for signal transduction: a computational study
F Mac Gabhann, AS Popel
Biophysical chemistry 128 (2-3), 125-139, 2007
1652007
Brain macrophages in simian immunodeficiency virus-infected, antiretroviral-suppressed macaques: a functional latent reservoir
CR Avalos, CM Abreu, SE Queen, M Li, S Price, EN Shirk, EL Engle, ...
MBio 8 (4), 10.1128/mbio. 01186-17, 2017
1382017
Systems biology of pro‐angiogenic therapies targeting the VEGF system
F Mac Gabhann, AA Qutub, BH Annex, AS Popel
Wiley Interdisciplinary Reviews: Systems Biology and Medicine 2 (6), 694-707, 2010
1112010
Collateral capillary arterialization following arteriolar ligation in murine skeletal muscle
FM Gabhann, SM Peirce
Microcirculation 17 (5), 333-347, 2010
1112010
Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model
F Mac Gabhann, AS Popel
American Journal of Physiology-Heart and Circulatory Physiology 288 (6 …, 2005
1102005
VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle
F Mac Gabhann, JW Ji, AS Popel
Journal of applied physiology 102 (2), 722-734, 2007
1052007
Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle
FM Gabhann, AS Popel
American Journal of Physiology-Heart and Circulatory Physiology 292 (1 …, 2007
1032007
Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapy
F Mac Gabhann, JW Ji, AS Popel
PLoS computational biology 2 (9), e127, 2006
942006
Increase of plasma VEGF after intravenous administration of bevacizumab is predicted by a pharmacokinetic model
MO Stefanini, FTH Wu, F Mac Gabhann, AS Popel
Cancer Research 70 (23), 9886-9894, 2010
922010
Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model
P Vempati, F Mac Gabhann, AS Popel
PloS one 5 (7), e11860, 2010
922010
Targeting neuropilin-1 to inhibit VEGF signaling in cancer: comparison of therapeutic approaches
FM Gabhann, AS Popel
PLoS computational biology 2 (12), e180, 2006
892006
The system can't perform the operation now. Try again later.
Articles 1–20